Notably, this overexpression is a common feature in uterine smooth muscle tumors and other mesenchymal neoplasms of gynecological origin, where specific molecular and genetic alterations result in the increased expression of HMGA2 [16]. The gene discussed is HMGA2; the disease is mesenchymal cell neoplasm.